State MI
Clinical Trials in Michigan
Michigan is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Michigan and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 351 actively recruiting studies with Michigan sites out of 351 registered in total. The busiest research areas in Michigan are Breast Cancer, Ovarian Cancer, Advanced Solid Tumor. Leading sponsors running trials in the state include University of Michigan, National Cancer Institute (NCI), AstraZeneca. By stage, Michigan trials break down as Phase 1 (64), Phase 2 (108), Phase 3 (88), Phase 4 (12).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in Michigan
Frequently Asked Questions — Clinical Trials in Michigan
How many clinical trials are currently recruiting in Michigan?
ClinicalMetric currently tracks 351 actively recruiting clinical trials with at least one location in Michigan. The total number of registered studies—including active but not currently enrolling trials—is 351. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Michigan?
Michigan hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Ovarian Cancer, Advanced Solid Tumor, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Michigan serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Michigan?
To join a clinical trial in Michigan, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Michigan maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Michigan
NCT04566328 Phase 3
Recruiting
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Mu...
Condition
Plasma Cell Myeloma
Enrollment
1,450 pts
Location
United States, Puerto Rico
Sponsor
ECOG-ACRIN Cancer Research Gro
NCT05147792 N/A
Recruiting
The CONFORM Pivotal Trial
Condition
Atrial Fibrillation
Enrollment
1,600 pts
Location
United States, Czechia, France
Sponsor
Conformal Medical, Inc
NCT05005975 Phase 3
Recruiting
Extension Study to Evaluate Safety and Tolerability of Oral Dersimelagon (MT-711...
Condition
EPP
Enrollment
301 pts
Location
United States, Australia, Belgium
Sponsor
Tanabe Pharma America, Inc.
NCT07225101 Phase 4
Recruiting
Evaluation of the Efficacy of STRATAFIX for Neurosurgical Cranial and Spine Proc...
Condition
Wound Closure
Enrollment
160 pts
Location
United States
Sponsor
University of Michigan
NCT05762107 Phase 2
Recruiting
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Condition
Type 1 Diabetes Mellitus With Hypoglycemia
Enrollment
186 pts
Location
United States, Canada
Sponsor
Zucara Therapeutics Inc.
NCT05086692 Phase 1, Phase 2
Recruiting
A Beta-only IL-2 ImmunoTherapY Study
Condition
Advanced Solid Tumor
Enrollment
115 pts
Location
United States, Australia, Canada
Sponsor
Medicenna Therapeutics, Inc.
NCT04077762 N/A
Recruiting
Radial Vs. State-Of-The-Art Femoral Access for Bleeding and Access Site Complica...
Condition
Patient Satisfaction
Enrollment
3,266 pts
Location
United States
Sponsor
Minneapolis Heart Institute Fo
NCT07094061 N/A
Recruiting
Neurobehavioral Signatures of Sign- and Goal-Tracking in Emerging Adults: Transl...
Condition
Substance Use
Enrollment
294 pts
Location
United States
Sponsor
University of Michigan
NCT07173751 Phase 3
Recruiting
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-N...
Condition
Breast Neoplasms
Enrollment
558 pts
Location
United States, Australia, Belgium
Sponsor
BioNTech SE
NCT06655246 Phase 1
Recruiting
A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gas...
Condition
Gastrointestinal Stromal Tumor (GIST)
Enrollment
157 pts
Location
United States
Sponsor
Kura Oncology, Inc.
NCT05556473 Phase 1
Recruiting
F-Tryptophan PET/CT in Human Cancers
Condition
Intracranial Glioma
Enrollment
24 pts
Location
United States
Sponsor
Barbara Ann Karmanos Cancer In
NCT03036319 N/A
Recruiting
Patient-Centered NeuroRehabilitation (PCN)
Condition
Cognitive Deficit
Enrollment
500 pts
Location
United States
Sponsor
University of Michigan
NCT06400472 Phase 1
Recruiting
A Study of LY4170156 in Participants With Selected Advanced Solid Tumors
Condition
Ovarian Neoplasms
Enrollment
495 pts
Location
United States, Australia, France
Sponsor
Eli Lilly and Company
NCT07356453 Phase 1
Recruiting
A Study of PARG Inhibitor FORX-428 in Patients With Advanced Solid Tumors.
Condition
Advanced Solid Tumors
Enrollment
40 pts
Location
United States
Sponsor
FoRx Therapeutics AG
NCT04851119 Phase 1, Phase 2
Recruiting
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including ...
Condition
Colorectal Carcinoma
Enrollment
147 pts
Location
United States
Sponsor
Children's Oncology Group
NCT05240014 N/A
Recruiting
Enhancing Voluntary Motion in Broad Patient Populations With Modular Powered Ort...
Condition
Lower-limb Orthoses
Enrollment
33 pts
Location
United States
Sponsor
University of Michigan
NCT05920733 N/A
Recruiting
Healthy Lifetime - Phase 2
Condition
Aging Well
Enrollment
120 pts
Location
United States
Sponsor
University of Michigan
NCT04532489 EARLY_Phase 1
Recruiting
Positron Emission Tomography (PET) Imaging of Cholesterol Trafficking: Clinical ...
Condition
Radiotracer
Enrollment
6 pts
Location
United States
Sponsor
Benjamin Viglianti
NCT06427538 N/A
Recruiting
Chest Drain Regular Flushing in Complicated Parapneumonic Effusions and Empyemas
Condition
Empyema, Pleural
Enrollment
96 pts
Location
United States
Sponsor
Vanderbilt University Medical
NCT06984835 N/A
Recruiting
Safety and Effectiveness of ELLANSÉ®-S Dermal Filler in the Treatment of Nasolab...
Condition
Nasolabial Folds
Enrollment
126 pts
Location
United States
Sponsor
AQTIS Medical B.V.
NCT07223840 Phase 2
Recruiting
A Study of Brenipatide in Adults Who Quit Smoking Cigarettes and Want to Avoid R...
Condition
Smoking
Enrollment
222 pts
Location
United States, China, Japan
Sponsor
Eli Lilly and Company
NCT04868604 Phase 1, Phase 2
Recruiting
64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-e...
Condition
Prostatic Neoplasms, Castration-Resistant
Enrollment
54 pts
Location
United States
Sponsor
Clarity Pharmaceuticals Ltd
NCT07322042 N/A
Recruiting
Evaluating Screening Adherence Between Moment for Parents App and Attention Cont...
Condition
Mental Health Screening Adherence
Enrollment
160 pts
Location
United States
Sponsor
Poisera, Inc.
NCT06337318 Phase 3
Recruiting
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor ...
Condition
Classic Follicular Lymphoma
Enrollment
600 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT06524882 Phase 3
Recruiting
Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of Age
Condition
Amblyopia
Enrollment
252 pts
Location
United States
Sponsor
Jaeb Center for Health Researc
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology